The GLP-1 Derivative NN2211 Restores β-Cell Sensitivity to Glucose in Type 2 Diabetic Patients After a Single Dose

• Published in: Diabetes (New York, N.Y.) Vol. 52; no. 7; pp. 1786 - 1791
• Main Authors: Chang, Annette M., Jakobsen, Grethe, Sturis, Jeppe, Smith, Marla J., Bloem, Cathie J., An, Bob, Galecki, Andrzej, Halter, Jeffrey B.
• Format: Journal Article
• Language: English
• Published: Alexandria, VA American Diabetes Association 01.07.2003
• Subjects: Aged; Biological and medical sciences; Blood Glucose - drug effects; Blood Glucose - metabolism; Cross-Over Studies; Diabetes Mellitus, Type 2 - drug therapy; Double-Blind Method; Female; Fundamental and applied biological sciences. Psychology; Glucagon - analogs & derivatives; Glucagon - physiology; Glucagon - therapeutic use; Glucagon-Like Peptide 1; Glucose Clamp Technique; Humans; Liraglutide; Male; Middle Aged; Peptide Fragments - physiology; Placebos; Protein Precursors - physiology; Reference Values

The GLP-1 Derivative NN2211 Restores β-Cell Sensitivity to Glucose in Type 2 Diabetic Patients After a Single Dose Annette M. Chang 1 , Grethe Jakobsen 2 , Jeppe Sturis 2 , Marla J. Smith 1 , Cathie J. Bloem 1 , Bob An 3 , Andrzej Galecki 4 and Jeffrey B. Halter 1 1 Department of Internal Medicine,...